Aromatherapy in the Treatment of Early Breast Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Early Breast Cancer
Interventions
OTHER

neoadjuvant chemotherapy

The neoadjuvant chemotherapy plan will be selected according to the recommendations of the NCCN guidelines and the Chinese CSCO guidelines for early breast cancer.The neoadjuvant chemotherapy plans include:AC-T(HP),TCb(HP),AC-TCb, in which A represents anthracycline, C represents cyclophosphamide, T represents taxane, Cb represents carboplatin, H represents trastuzumab, and P represents pertuzumab.

OTHER

aromatherapy

Patients will inhale essential oils during the neoadjuvant chemotherapy courses.

Trial Locations (1)

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06435104 - Aromatherapy in the Treatment of Early Breast Cancer | Biotech Hunter | Biotech Hunter